Radiofrequency ablation, a minimally invasive procedure that involves inserting a needle-like device into uterine fibroids through the abdomen, is being trialled as an alternative for women needing a hysterectomy.

Radiofrequency ablation is approved by the US Food and Drug Administration for other purposes, including combating liver and lung tumours and is in Phase III trials for uterine fibroids, the Wall Street Journal reports.

Radiofrequency ablation is a procedure that involves inserting a device into the fibroid through the abdomen and heating it with low-frequency electrical current.

Medical centres in the US, Mexico and Guatemala are enrolling women for the trial.